Gene · 406932
Papers3,316
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,316
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer. | J Cancer Res Clin Oncol | 2024 | 38285101 | PubTator, text mining | PubMed |
| Regulatory Non-Coding RNAs during Porcine Viral Infections: Potential Targets for Antiviral Therapy. | Viruses | 2024 | 38257818 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression. | Int J Mol Sci | 2024 | 38256011 | PubTator, text mining | PubMed |
Involvement of Yes-Associated Protein 1 Activation in the Matrix Degradation of Human-Induced-Pluripotent-Stem-Cell-Derived Chondrocytes Induced by T-2 Toxin and Deoxynivalenol Alone and in Combination. | Int J Mol Sci | 2024 | 38255951 | PubTator, text mining | PubMed |
| Molecular Biology of Meniscal Healing: A Narrative Review. | Int J Mol Sci | 2024 | 38255841 | PubTator, text mining | PubMed |
| Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms. | Int J Mol Sci | 2024 | 38255835 | PubTator, text mining | PubMed |
| Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential. | Int J Mol Sci | 2024 | 38255791 | PubTator, text mining | PubMed |
| Role of microRNAs deregulation in initiation of rheumatoid arthritis: A retrospective observational study. | Medicine (Baltimore) | 2024 | 38241560 | PubTator, text mining | PubMed |
| MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer. | Transl Oncol | 2024 | 38235618 | PubTator, text mining | PubMed |
| The role of microRNAs in brain metastasis. | J Neurooncol | 2024 | 38194195 | PubTator, text mining | PubMed |
| Small RNA-big impact: exosomal miRNAs in mitochondrial dysfunction in various diseases. | RNA Biol | 2024 | 38174992 | PubTator, text mining | PubMed |
| Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review. | J Nanobiotechnology | 2024 | 38172932 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential. | J Cancer | 2024 | 38169510 | PubTator, text mining | PubMed |
| The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. | BMC Cancer | 2024 | 38166752 | PubTator, text mining | PubMed |
| LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p. | Heliyon | 2024 | 38163156 | PubTator, text mining | PubMed |
| A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. | Obstet Gynecol Sci | 2024 | 38050353 | PubTator, text mining | PubMed |
| Exosomal derived miR-1246 from hydroquinone-transformed cells drives S phase accumulation arrest by targeting cyclin G2 in TK6 cells. | Chem Biol Interact | 2024 | 38006958 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| Epigenetic modifications: Key players in cancer heterogeneity and drug resistance. | Transl Oncol | 2024 | 37931371 | PubTator, text mining | PubMed |
| Pathological mechanisms of amyotrophic lateral Sclerosis. | Neural Regen Res | 2024 | 37862206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406932/papers?page=5